Bruker Corp. Stock
Bruker Corp. Stock
A loss of -2.030% shows a downward development for Bruker Corp..
Bruker Corp. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
With a target price of 48 € there is a positive potential of 24.87% for Bruker Corp. compared to the current price of 38.44 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -2.030% | -6.790% | 4.855% | -31.234% | -30.689% | - | - |
| Integer Hldg | - | 2.521% | 1.667% | -53.788% | -51.969% | -9.630% | -3.937% |
| Healthequity Inc. | 1.860% | 2.500% | -4.094% | -9.392% | -9.890% | 37.815% | 53.271% |
| Omnicell Inc. | -3.700% | 5.202% | 14.465% | -16.514% | -12.500% | -19.469% | -61.684% |
Comments
Bruker (NASDAQ:BRKR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $60.00 price target on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a
Why Bruker Stock Tumbled by Almost 12% Wednesday
Medical device and diagnostics company Bruker (NASDAQ: BRKR) wasn't looking like the cure for any investor's ailments on Wednesday. The stock was hit with an assertive sell-off from the market